Market Overview:
The global thrombophilia testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of thrombophilia, technological advancements in thrombophilia testing, and rising demand for point-of-care tests. However, the high cost of tests and limited reimbursement are expected to restrain the growth of this market during the forecast period. On the basis of type, automated testing is expected to account for a larger share of the global thrombophilia testing market than semi-automated testing during the forecast period. This can be attributed to technological advancements in automated blood clotting assays that have led to increased accuracy and efficiency in diagnosis. Oncology clinics are increasingly adopting automated systems for complete blood count (CBC) analysis as it offers significant benefits such as reduced turnaround time and improved patient care.
Product Definition:
Thrombophilia Testing is a blood test that screens for abnormalities in the blood that may increase your risk of developing a blood clot. The main use of Thrombophilia Testing is to help identify people who are at an increased risk of developing a life-threatening blood clot, such as deep vein thrombosis (DVT) or pulmonary embolism (PE).
Automated Testing:
Automated testing is a technique that involves the use of software programs to observe and examine the functionality of various components in a system. In other words, automated tests are used to check if the developed software/application meets all its functional requirements. These tests are also known as unit or integration tests or just simply as automation test; they help in determining whether all individual modules/components of an application work correctly and meet expectations.
Semi-automated Testing:
Semi-automated thrombophilia testing is a new approach to the market that has been developed in order to overcome the limitations of manual testing. The main objective of this method is to reduce human influence and hence increase test accuracy. This technology involves computer software, which helps in analyzing and processing the sample with high speed and precision.
Application Insights:
The specialty clinics segment dominated the global thrombophilia testing market in 2017. This is attributed to factors such as increasing awareness about thrombophilia and rising prevalence of coagulation disorders. According to a study published by NCBI, it has been estimated that around 1% of the total population of developed countries have a disorder characterized by abnormal platelet function. In addition, around 2% of the total population has a condition where they are at an increased risk for developing cardiovascular diseases due to their coagulation defect.
According to data published in NCBI, approximately 60 million people across the globe have suffered from venous thromboembolism (VTE) events during their lifetime and this number is expected to increase with aging along with associated risk factors such as immobility and cancer which increases VTE incidence rate significantly.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies and increasing incidence of coagulation disorders &bleeding disorders. Moreover, favorable reimbursement policies are also expected to drive growth during the forecast period. Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising healthcare expenditure and improving healthcare infrastructure in this region.
Growth Factors:
- Increasing incidence of thrombophilia
- Growing awareness about thrombophilia and its diagnosis and treatment options
- Rising demand for point-of-care testing for thrombophilia
- Technological advancements in the field of thrombophilia testing 5. Growing number of clinical studies on thrombophilia
Scope Of The Report
Report Attributes
Report Details
Report Title
Thrombophilia Testing Market Research Report
By Type
Automated Testing, Semi-automated Testing
By Application
Hospitals, Specialty Clinics, Diagnostic Laboratories
By Companies
Siemens, LabCorp, Instrumentation Laboratory SpA, Johns Hopkins Medicine, Abbott
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
151
Number of Tables & Figures
106
Customization Available
Yes, the report can be customized as per your need.
Global Thrombophilia Testing Market Report Segments:
The global Thrombophilia Testing market is segmented on the basis of:
Types
Automated Testing, Semi-automated Testing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialty Clinics, Diagnostic Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Siemens
- LabCorp
- Instrumentation Laboratory SpA
- Johns Hopkins Medicine
- Abbott
Highlights of The Thrombophilia Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Automated Testing
- Semi-automated Testing
- By Application:
- Hospitals
- Specialty Clinics
- Diagnostic Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Thrombophilia Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Thrombophilia testing is a blood test that checks for abnormal levels of blood platelets. Platelets are important cells in the body that help to prevent bleeding.
Some of the major players in the thrombophilia testing market are Siemens, LabCorp, Instrumentation Laboratory SpA, Johns Hopkins Medicine, Abbott.
The thrombophilia testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Thrombophilia Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Thrombophilia Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Thrombophilia Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Thrombophilia Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Thrombophilia Testing Market Size & Forecast, 2018-2028
4.5.1 Thrombophilia Testing Market Size and Y-o-Y Growth
4.5.2 Thrombophilia Testing Market Absolute $ Opportunity
Chapter 5 Global Thrombophilia Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Thrombophilia Testing Market Size Forecast by Type
5.2.1 Automated Testing
5.2.2 Semi-automated Testing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Thrombophilia Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Thrombophilia Testing Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialty Clinics
6.2.3 Diagnostic Laboratories
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Thrombophilia Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Thrombophilia Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Thrombophilia Testing Analysis and Forecast
9.1 Introduction
9.2 North America Thrombophilia Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Thrombophilia Testing Market Size Forecast by Type
9.6.1 Automated Testing
9.6.2 Semi-automated Testing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Thrombophilia Testing Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialty Clinics
9.10.3 Diagnostic Laboratories
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Thrombophilia Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Thrombophilia Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Thrombophilia Testing Market Size Forecast by Type
10.6.1 Automated Testing
10.6.2 Semi-automated Testing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Thrombophilia Testing Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialty Clinics
10.10.3 Diagnostic Laboratories
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Thrombophilia Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Thrombophilia Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Thrombophilia Testing Market Size Forecast by Type
11.6.1 Automated Testing
11.6.2 Semi-automated Testing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Thrombophilia Testing Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialty Clinics
11.10.3 Diagnostic Laboratories
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Thrombophilia Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Thrombophilia Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Thrombophilia Testing Market Size Forecast by Type
12.6.1 Automated Testing
12.6.2 Semi-automated Testing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Thrombophilia Testing Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialty Clinics
12.10.3 Diagnostic Laboratories
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Thrombophilia Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Thrombophilia Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Thrombophilia Testing Market Size Forecast by Type
13.6.1 Automated Testing
13.6.2 Semi-automated Testing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Thrombophilia Testing Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialty Clinics
13.10.3 Diagnostic Laboratories
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Thrombophilia Testing Market: Competitive Dashboard
14.2 Global Thrombophilia Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Siemens
14.3.2 LabCorp
14.3.3 Instrumentation Laboratory SpA
14.3.4 Johns Hopkins Medicine
14.3.5 Abbott
